Analyst Ratings for Pluristem Therapeutics (PSTI)
PSTI Rating Summary
PSTI Price Target Summary
- Highest: $5.00 (Needham & Company)
- Lowest: $3.50 (Jefferies)
- Average: $4.50
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.50 (+47.5%)
Avg. $ Target:
$4.50 (+47.5%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/19/2013 | Jefferies | New Coverage | Hold (N/A) |
3.50 (N/A) |
3.17 | 3.05 | -3.79% | Details |
| 7/24/2012 | WBB Securities | Downgrade | Hold (Speculative Buy) |
N/A (N/A) |
3.40 | 3.05 | -10.29% | Details |
| 5/22/2012 | Needham & Company | New Coverage | Buy (N/A) |
5.00 (N/A) |
2.65 | 3.05 | 15.09% | Details |
| 12/9/2011 | Global Hunter Securities | New Coverage | Buy (N/A) |
5.00 (N/A) |
2.48 | 3.05 | 22.98% | Details |
| 6/17/2011 | Dawson James | New Coverage | Market Outperform (N/A) |
N/A (N/A) |
2.90 | 3.05 | 5.17% | Details |
| 5/17/2011 | Oppenheimer | New Coverage | Outperform (N/A) |
N/A (N/A) |
2.56 | 3.05 | 19.14% | Details |
